Targeting the translation machinery in cancer
The DOI matches its Crossref record; 291 of the 291 references it cites were found in a registry or an index.
Abstract
Dysregulation of mRNA translation is a frequent feature of neoplasia. Many oncogenes and tumour suppressors affect the translation machinery, making aberrant translation a widespread characteristic of tumour cells, independent of the genetic make-up of the cancer. Therefore, therapeutic agents that target components of the protein synthesis apparatus hold promise as novel anticancer drugs that can overcome intra-tumour heterogeneity. In this Review, we discuss the role of translation in cancer, with a particular focus on the eIF4F (eukaryotic translation initiation factor 4F) complex, and provide an overview of recent efforts aiming to 'translate' these results to the clinic.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The natural product, silvestrol, and related compounds are selective and potent inhibitors of the RNA helicase and translation initiation factor eIF4A (Eukaryotic Translational Initiation Factor 4A, also known as DDX2) [20].”
From NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy (2021) · cites this paper as [20]
In the citing paper
“Our results build on studies in mouse models of other cancers, including lymphoma, leukemia, breast, prostate, and pancreatic cancer, supporting the tolerability and efficacy of eIF4A inhibitors (15, 17, 20, 21, 38).”
From Targeting eIF4A-dependent translation in genetically complex sarcoma (2026) · cites this paper as [38]
In the citing paper
“Many direct eIF4A/eIF4F mRNA targets have been identified and often encode proteins that drive proliferation, metastasis, and survival (11, 14, 15).”
From Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer (2023) · cites this paper as [14]
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Wolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2775 · Cited by 4,434
Insights into the regulation of protein abundance from proteomic and transcriptomic analyses
Vogel, C., & Marcotte, E. M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3185 · Cited by 4,195
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
Research works printed but not linked: 5
- Hershey, J. W. B., Sonenberg, N. & Mathews, M. in Protein Synthesis and Translational Control (eds Hershey, J. W. B. et al.) (Cold Spring Harbor Laboratory Press, 2012)
- Pianese, G. Beitrag zur histologie und aetiologie der carcinoma histologische und experimentelle. Beitr. Pathol. Anat. Allg. Pathol. 142, 1–193 (in German) (1896). First evidence that dysregulated translation has a major role in cancer by demonstrating that cancer cells have hypertrophic and irregularly shaped nucleoli.
- De Benedetti, A. et al. CHO cells transformed by the translation factor elF-4E display increased c-Myc expression, but require overexpression of Max for tumorigenicity. Mol. Cell. Diff. 2, 347–371 (1994).
- Ron, D. & Harding, H. in Translational Control in Biology and Medicine Ch. 13 (eds Matthews, M. B. et al.) (Cold Spring Harbor Laboratory Press, 2007).
- Bissler, J. J. et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N. Engl. J. Med. 358, 140–151 (2008). · DOI · Paper page
Cited by
Items 701–800 of 899
Autophagy markers expression pattern in developing liver of the yotari (dab1 -/-) mice and humans
Maras, E. D., Kelam, N., Racetin, A., Haque, E., Dražić, M., Vukojević, K., Katsuyama, Y., Saraga‐Babić, M., & Filipović, N. (2024) · Acta Histochemica · doi:10.1016/j.acthis.2024.152224 · Cited by 1
A gyógyszerkutatás új irányzatai: hatékonyság és biztonságosság
Kotschy, A. (2021) · Scientia et Securitas · doi:10.1556/112.2021.00028 · Cited by 1
Impact of silencing eEF2K expression on the malignant properties of chordoma
Aydemir, E., Tüysüz, E. C., Bayrak, Ö. F., Tecimel, D., Deniz, A. A. H., & Şahin, F. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08257-z · Cited by 1
“Protein synthesis is an essential cellular process for cell vialbility and is accomplished by the action of a humbling machinery comprised of several factors acting in a highly sophisticated and meticulously orchestrated fashion [16].”
BackgroundGao, M., & Huang, Y. (2024) · Physical Chemistry Chemical Physics · doi:10.1039/d3cp04899c · Cited by 1
Canada's contributions to RNA research: past, present, and future perspectives
Lécuyer, É., Sauvageau, M., Kothe, U., Unrau, P. J., Damha, M. J., Perreault, J., Elela, S. A., Bayfield, M. A., Claycomb, J. M., & Scott, M. S. (2024) · Biochemistry and Cell Biology · doi:10.1139/bcb-2024-0176 · Cited by 1
Novel payloads for immunotoxin-based treatment of neuroblastoma
Rust, A. (2016) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 1
Kashinskaya, D. (2017) · theses.fr (ABES) · doi:10.70675/8b58987cz0034z4d36zb433z10dfe3f9a246 · Cited by 1
Elucidating the role of human obg like ATPase1 (hOLA1) in apoptosis
Balasingam, N. (2017) · Open ULeth Scholarship (OPUS) (University of Lethbridge) · Cited by 1
Gil, S. C. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
The Molecular Mechanisms Underlying the Cancer Killing Effect of Interleukin-24
Persaud, L. (2019) · CUNY Academic Works (City University of New York) · Cited by 1
Deciphering the Functional Roles of Centrosomal Protein 55 (CEP55) in Development and Cancer
Rashidieh, B. (2020) · Griffith Research Online · doi:10.25904/1912/3496 · Cited by 1
Hulea, L., Gravel, S., Morita, M., Cargnello, M., Uchenunu, O., Im, Y. K., McLaughlan, S., Larsson, O. S., Ohh, M., Ferreira, T., et al. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3155732 · Cited by 1
Self-citationInvestigation of the Biological Effect of eIF4A Reduction and Inhibition
Little, R. (2020) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17145923.v1 · Cited by 1
The Eukaryotic mRNA Cap Structure
Pelletier, J., & Sonenberg, N. (2023) · Wiley eBooks · doi:10.1002/9780470015902.a0029559 · Cited by 1
Self-citationSun, H., Jiao, D., Zhao, X., Chen, Y., Shi, Q., Lv, Z., Li, Y., Gao, K., & Wang, C. (2023) · eLife · doi:10.7554/elife.92236.1 · Cited by 1
Lee, Y. S., Good, J., Awais, N., Eschle, B. K., Lineberry, M. S., Teo, J. L., Bibeau, S., Wollman, M., Karadimov, G. I., Sariipek, N. E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.20.629809 · Cited by 1
Programmable translational inhibition by a molecular glue-oligonucleotide conjugatePreprint
Wang, S., Kovalski, J. R., Belinchón, F. J. Z., Bennett, M., Kuzuoğlu‐Öztürk, D., Li, Q., Stevenson, E. J., Liu, J., Krogan, N. J., Ott, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.15.664547 · Cited by 1
PI3K/mTOR activity sensitizes cancer cells to nucleolar stressPreprint
Barz, M., Corman, A., Häggblad, M., Gonzalez-Serrano, A., Lidemalm, L., Murga, M., Hühn, D., & Fernández-Capetillo, Ó. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.12.688066 · Cited by 1
Dynamic Control of Translation During Adult Neurogenesis
Baser, A. (2017) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00022978 · Cited by 1
Tumor-targeted delivery of Cas9 mRNA and sgRNA against KRAS-mutated lung cancer
Chen, S. (2024) · doi:10.5282/edoc.34484 · Cited by 1
Zuo1 - a novel G-quadruplex binding protein in \(Saccharomyces\) \(cerevisiae\)
Götz, S. (2017) · Online Publication Service of Würzburg University (Würzburg University) · Cited by 1
Axonal mRNA localisation and the development of peripheral sensitisation in vitro
Arendt-Tranholm, A. (2022) · Nottingham ePrints (University of Nottingham) · Cited by 1
Uchenunu, O. (2023) · eScholarship@McGill (McGill) · doi:10.82308/43084 · Cited by 1
Roscioni, A., D’Amore, V. M., Rexha, J., Bianchini, G. R., Teana, A. L., Marino, D. D., Romagnoli, A., & Leva, F. S. D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.23.696204 · Cited by 1
“Protein translation represents a critical process in cancer cells, which are highly dependent on the rapid production of oncogenic proteins to survive and adapt to environmental stress 12–16 .”
Di-codon organization links tRNA modifications to cancer cell proteome compositionPreprint
Moghaddam, K. H., Timpone, C., Gowda, L. N., Tutuka, C. A., Risbridger, G. P., Steele, J. R., Schittenhelm, R. B., Kusnadi, E. P., Furic, L., & Larsson, O. S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.10.710911 · Cited by 1
Bentayeb, H. (2016) · theses.fr (ABES) · doi:10.70675/e9d3a868z56bfz4a6aza457z230cc64e1da9 · Cited by 1
Gross, L. (2018) · theses.fr (ABES) · doi:10.70675/c49589fazfc73z47d7z9ab8zca0524c65317 · Cited by 1
Brunet, L. (2021) · theses.fr (ABES) · doi:10.70675/a4e459eez153dz4ec7z924fza1c1c6e4fdd6 · Cited by 1
mTOR inactivation governs adaptive survival to ribosome biogenesis deficiency
Fan, W., Liu, H., Yang, L., Sinha, N. K., Catipovic, M. A., Dong, D., Easwaran, H., Green, R., & Laiho, M. (2026) · Genes & Development · doi:10.1101/gad.353708.126 · Cited by 1
Targeting eIF4A-dependent translation in genetically complex sarcoma
Kim, Y.-M., Mohan, P., Sehrawat, U., Seffar, E., De Queiroz, R. M., Chadalavada, K., Persaud, N., Okada, T., Kulkarni, A., Lin, J., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.192936
“Our results build on studies in mouse models of other cancers, including lymphoma, leukemia, breast, prostate, and pancreatic cancer, supporting the tolerability and efficacy of eIF4A inhibitors (15, 17, 20, 21, 38).”
Shin, S., Liauzun, M., Solorzano, J., Bras, M. L., Jean, C., Fourneaux, B., Dore, M., Fevrier, L., Belhabib, I., Brunel, A., et al. (2026) · Advanced Science · doi:10.1002/advs.202515740
Abstract A49: Inhibition of mTOR induces chemoresistance in B-cell acute lymphoblastic leukemia
Vo, T.-T. T., Nguyen, D. M., Lui, B., Lu, M., Mallya, S., & Fruman, D. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1538-8514.pi3k14-a49
Novel players in human ribosome synthesis: The ANN complex and the transcription factor JAZF1
Bammert, L. (2016) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-010697241
Fritz, S. E. (2015) · OhioLink ETD Center (Ohio Library and Information Network)
Molecular Mechanism of the Ded1p-eIF4F Complex
Gao, Z. (2016) · OhioLink ETD Center (Ohio Library and Information Network)
Metabolic phenotype analysis in patients with pulmonary hypertension
Ghataorhe, P. (2016) · doi:10.25560/45357
Kelly, N. J. (2017) · The Atrium (University of Guelph)
Sonenberg, N. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716203114
Self-citationSatler, J. D., Carstens, B. C., & Hedin, M. C. (2015) · DRYAD · doi:10.5061/dryad.68s40.2/3.2
Investigating the role of mRNA capping enzyme in C-MYC function
Lombardi, O. (2017) · Discovery Research Portal (University of Dundee)
Chemical and CRISPR/Cas9 Tools for Functional Characterization of RNA Helicases
Chu, J., & Pelletier, J. (2018) · Springer eBooks · doi:10.1007/978-981-10-8372-3_14
Self-citationCharacterisation of the cellular response to defective translational termination
Ploumakis, A. (2018) · University of Birmingham Institutional Research Archive (University of Birmingham)
Integrative modeling of inhibitor response in breast cancer cells
Thijssen, B. (2018) · Research Repository (Delft University of Technology) · doi:10.4233/uuid:8f52bab6-c097-4c4c-8291-3e76b0285f55
Saad, N. (2016) · Nottingham ePrints (University of Nottingham)
Regulation of protein metabolism in skeletal muscle of low-birth-weight neonatal pigs
Chen, Y. (2017) · VTechWorks (Virginia Tech)
Exploring new paradigms of translational control in eukaryotes
Bulfoni, M. (2018) · theses.fr (ABES) · doi:10.70675/a8d5cb7az8338z4046zbcb9z465326fdcd0b
THE ROLE OF GENE EXPRESSION NOISE IN MAMMALIAN CELL SURVIVAL
Farquhar, K. S. (2019) · Digital Commons-TMC (Texas Medical Center)
The role of MAPK signalling pathways in leukemic cell death
Cordingley, M. (2018) · ChesterRep (University of Chester)
Mitchell, D. C. (2019) · Deep Blue (University of Michigan)
Yi, T. (2016) · Journal of Pharmaceutical and Pharmacological Sciences · doi:10.29011/2574-7711.100002
“Many oncogenic mRNAs, which encode oncoproteins with low abundance while important for cancer cell survival, proliferation and growth, contain long and /or highly structured 5’-untranslated regions (5’-UTRs) with low translational efficiency (Figure 1) [6].”
BackgroundRôle de MITF et du métabolisme des sphingolipides dans le mélanome cutané
Leclerc, J. (2019) · theses.fr (ABES) · doi:10.70675/e6ceb3b4z96a2z4196za809z97cd83844103
Examining the Influence of Muscle Fiber Type on Protein Turnover Signaling in Growing Pigs
Seymour, K. T. (2020) · VTechWorks (Virginia Tech)
Investigating mechanisms of acquired resistance to the AKT inhibitor capivasertib (AZD5363)
Jakubowski, J. M. (2019) · Kent Academic Repository (University of Kent)
Reoviral Cytolysis is Modulated by Stemness
Bourhill, T. (2020) · doi:10.11575/prism/38336
Zhao, Y., Li, T., Tian, S., Meng, W., Yang, J., Wang, B., Liang, Z., Zhao, H., Han, Y., Tang, Y., et al. (2020) · doi:10.21203/rs.3.rs-19096/v1
Bayoumi, A. (2020) · The Sydney eScholarship Repository (The University of Sydney)
Adaptation of Chemical Biology Approaches for Dissecting Disordered Protein Dynamics
Johnson, O. (2018) · Deep Blue (University of Michigan)
Venom and Toxin as Targeted Therapy
Kwok, H. F. (2019) · MDPI eBooks · doi:10.3390/books978-3-03921-190-6
APPLE and translation: When a small peptide produced from a “non-coding RNA” matters!
Mohapatra, S., & Călin, G. A. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.10.012
The impact of the integrated stress response on DNA replication
Choo, J. A. M. Y. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7917
Clairambault, J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736040460.793575381
Gillet, J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733580901.793581211
Pettersson, U. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737326194.793573085
Li, F., Sun, H., Li, Y., Bai, X., Dong, X., Zhao, N., Meng, J., Sun, B., & Zhang, D. (2021) · Research Square · doi:10.21203/rs.3.rs-168436/v2
Nanomaterials for Gene Therapy
Karthik, V., Arumugam, V., Raj, D. D. D., Nagarjun, T. G. N., Poornima, S., Subbaiya, R., & Saravanan, M. (2022) · Wiley eBooks · doi:10.1002/9781119558026.ch6
Thompson, P. A., Eam, B., Young, N. P., Fish, S., Chen, J. W., Barrera, M., Howard, H., Sung, E., Parra, A., Staunton, J., et al. (2023) · doi:10.1158/1535-7163.c.6542892
Zhao, X., Li, J., Liu, Z., & Powers, S. (2023) · doi:10.1158/0008-5472.c.6565183.v1
PI 3 Kinase, AKT , and m TOR Inhibitors
McCay, J., & Gribben, J. G. (2023) · Wiley eBooks · doi:10.1002/9781119819950.ch9
Biosimilars in Dermatology: A Promising Solution to The High Cost of Biologic Therapy
Hussein, R., & Dayel, S. B. (2023) · International Journal of Life Science and Pharma Research · doi:10.22376/ijlpr.2023.13.5.p110-p115
Fueling fate: Metabolic crosstalk in the bone marrow microenvironment
Lisi-Vega, L. E., & Méndez‐Ferrer, S. (2023) · Advances in stem cells and their niches · doi:10.1016/bs.asn.2023.08.001
The Role of eIF2B Localisation in Cell-specific Stress Responses
Hanson, F. M. (2023) · Sheffield Hallam University · doi:10.7190/shu-thesis-00555
Norman, J. C., Moore, M. H., Pardo, L., Mitchell, L. E., Schmidt, T., Waldron, J. A., May, S., Müller, M., Smith, R. C. L., Strathdee, D., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3891270/v1
Hung, Y., Ouyang, C., Ping, X., Qi, Y., Wang, Y.-C., Kung, H.-J., & Ann, D. K. (2023) · Figshare · doi:10.6084/m9.figshare.23084148
Gu, J., Han, F., Chen, S., & Zhang, Q. (2023) · Figshare · doi:10.6084/m9.figshare.23119000
Jiao, D., Sun, H., Zhao, X., Chen, Y., Lv, Z., Shi, Q., Li, Y., Wang, C., & Gao, K. (2024) · eLife · doi:10.7554/elife.92236.2
5’UTR translational inhibition of neuroblastoma dependency factors using the CR-1-31-B rocaglatePreprint
Nunes, C., Bekaert, S., Parsa, S., Nelen, I. H., Martens, F., de Stanchina, E., Sanders, E., Hilgert, E., T’Sas, S., Zhao, P., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.29.610236
Targeting the translation initiation complex in therapy-resistant and metastatic melanomaPreprint
Feng, Y., Diaz-Olea, X., Ke, X., Radaeva, M., Amiri, M., Joo, H., Jafari, M., Kim, H., Deshpande, A. J., Olson, S. H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.20.624566
Self-citationLi, Y., Gao, Q., Tang, Y., Shao, Z., Hu, J.-M., Liu, Z., Shi, A., Huang, S., Xu, Y., Zhang, Z., et al. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101619
“36 Precise regulation of translation levels affects tumor progression and metastasis.”
NOC4L serves as a novel prognostic marker and therapeutic target for lung adenocarcinoma
Wang, M., Lv, Y., Wang, Z., Mprah, R., Ding, Y., Li, C., & Xue, M. F. (2025) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2025.100274
Nucleic acid based molecular markers in the diagnosis of cancer
Kumari, A., & Kumar, V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22300-6.00048-6
Pullaiahgari, D., Baron, N., Purushotham, R., Kamus-Elimeleh, D., Dror, S., Levin, L., & Shapira, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.16.665100
Hexavalent chromium promotes malignant transformation via enhanced translation of SUV39H1
Gu, Y., Cao, Y., Ye, Q., Zhang, Y., Wang, Z., Yang, C., Liu, S., & She, Q. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111869
Wu, C.-F. (2016) · Gutenberg Open Science · doi:10.25358/openscience-2488
Meng, W., Xiao, H., Zhao, R., Chen, J., Yangwei, W., Mei, P., Li, H., & Liao, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26669199
Meng, W., Xiao, H., Zhao, R., Chen, J., Yangwei, W., Mei, P., Li, H., & Liao, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26669202
Iglesias‐Pedraz, J. M., Fossatti-Jara, D. M., Valle-Riestra-Felice, V., Cruz-Visalaya, S. R., Ayala Felix, J. A., & Comai, L. (2020) · Figshare · doi:10.6084/m9.figshare.13093876
Iglesias‐Pedraz, J. M., Fossatti-Jara, D. M., Valle-Riestra-Felice, V., Cruz-Visalaya, S. R., Ayala Felix, J. A., & Comai, L. (2020) · Figshare · doi:10.6084/m9.figshare.13093858
Hung, Y., Ouyang, C., Ping, X., Qi, Y., Wang, Y.-C., Kung, H.-J., & Ann, D. K. (2023) · Figshare · doi:10.6084/m9.figshare.23084145
Iglesias‐Pedraz, J. M., Fossatti-Jara, D. M., Valle-Riestra-Felice, V., Cruz-Visalaya, S. R., Ayala Felix, J. A., & Comai, L. (2020) · Figshare · doi:10.6084/m9.figshare.13093870
Fooks, K., Galicia-Vázquez, G., Gife, V., Schcolnik‐Cabrera, A., Nouhi, Z., Poon, W. W. L., Luo, V. M., Rys, R. N., Aloyz, R. S., Orthwein, A., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22614635
Self-citation
Metadata
- Authors
- Bhat, M., Robichaud, N., Hulea, L., Sonenberg, N., Pelletier, J., & Topisirovic, I.
- Affiliations
- McGill University Health Centre (CA)
- McGill University (CA)
- Jewish General Hospital (CA)
- Corresponding author
- Sonenberg, Nahum
- Pelletier, Jerry
- Venue
- Nature Reviews Drug Discovery
- Published
- 2015-03-06
- Volume
- 14
- Issue
- 4
- Pages
- 261-278
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2040885133
- Cited by
- 799
- References
- 291
- Citations by year
- 2026: 40 · 2025: 44 · 2024: 69 · 2023: 77 · 2022: 58 · 2021: 75 · 2020: 92 · 2019: 70 · 2018: 89 · 2017: 99 · 2016: 65 · 2015: 19
- FWCI
- 8.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@McGill (McGill) (submittedVersion)
- Funders
- Howard Hughes Medical Institute (55007654)
- Canadian Institutes of Health Research (MOP115-195, MOP#115126, 106530_1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Keywords
- mRNA translation, translation machinery, cancer, eIF4F, translation initiation, oncogenes, tumour suppressor, anticancer agents, intra-tumour heterogeneity, drug development
- MeSH terms
- Animals, Antineoplastic Agents, Humans, Neoplasms, RNA, Messenger, Protein Biosynthesis, Gene Expression Regulation, Neoplastic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.